Roginolisib
- Generic Name
- Roginolisib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H27FN4O5S
- CAS Number
- 1305267-37-1
- Unique Ingredient Identifier
- 6K8FC2TF54
- Associated Conditions
- -
- Associated Therapies
- -
Study of Roginolisib in UM Patients
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- iOnctura
- Target Recruit Count
- 85
- Registration Number
- NCT06717126
Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-16
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Jennifer R. Brown, MD, PhD
- Target Recruit Count
- 64
- Registration Number
- NCT06644183
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath